Chunjie Gong | Molecular Biology | Best Researcher Award

Prof. Chunjie Gong | Molecular Biology | Best Researcher Award

Professor at Hubei University of Technology, China

Dr. Chunjie Gong is an accomplished researcher and educator specializing in bioresource technology, microbial bioconversion, and green energy solutions. With a career spanning over two decades, Dr. Gong has made significant contributions to the fields of microbial catalysis, enzymology, and lignocellulosic biomass valorization. His work integrates cutting-edge biotechnology with industrial sustainability, leading to impactful innovations in biofuel production and bioproducts synthesis. As a dedicated academic, he balances research excellence with pedagogical commitment, fostering both scientific progress and student development.

profile

scopus

Education

Dr. Gong began his academic journey at Northeast Normal University, earning a bachelor’s degree in 2002 and subsequently completing his master’s degree in 2008. Driven by a passion for advanced scientific inquiry, he pursued a Ph.D. at Kyoto University, Japan, completing his doctoral studies in 2013. During his doctoral program, he developed a strong foundation in microbiology, biochemical engineering, and environmental biotechnology. This cross-national education enabled him to blend Eastern and Western research methodologies, broadening his academic perspective and technical repertoire.

Experience

Following his master’s graduation, Dr. Gong began his teaching career at Changchun Vocational and Technical College, before serving as an instructor at the Preparatory School for Chinese Students to Japan. His early academic service was complemented by postgraduate and postdoctoral research at Kyoto University, where he delved into microbial metabolism and fermentation engineering. Since 2014, Dr. Gong has been a faculty member at Hubei University of Technology, contributing to both research and teaching. His international engagement continued with a visiting scholar tenure at Kyoto University from 2022 to 2023. Across these roles, Dr. Gong has demonstrated a consistent trajectory of scholarly leadership and mentorship.

Research Interest

Dr. Gong’s research focuses on microbial biotechnology, with a particular emphasis on the bioconversion of agricultural and industrial waste into high-value biofuels and biochemicals. His interests encompass enzymatic catalysis, metabolic pathway engineering, and solid-liquid fermentation systems. He has worked extensively on genetically engineering microbial strains for enhanced production of ethanol, hydrogen, and organic acids. Dr. Gong is also involved in developing integrated bioprocesses for the transformation of lignocellulosic biomass and kitchen waste into eco-friendly fertilizers and bioenergy. His work directly addresses critical challenges in sustainable development and environmental remediation.

Awards

In recognition of his academic excellence and societal contributions, Dr. Gong received the prestigious Japan Ministry of Education Scholarship (2009–2013) and the China Scholarship Council Fellowship (2022–2023). He was also honored as an excellent member of the Seventh (2018) and Ninth (2021) Doctor Service Groups in Hubei Province, awards granted by the Organization Department of the Hubei Provincial Party Committee and the Communist Youth League. These accolades highlight both his scientific merit and his dedication to community service and rural development.

Publications

Dr. Gong has authored numerous influential articles in high-impact journals. Selected recent publications include:

Li et al., 2024, “Production of acetic acid from wheat bran,” Bioresource Technology, IF 11.4 – Cited by 5 articles.

Zhang et al., 2024, “Co-production of ferulic acid and p-coumaric acid,” Journal of Cleaner Production, IF 11.1 – Cited by 4 articles.

Xue et al., 2024, “Ethyl lactate biosynthesis via aerobic-anaerobic cascade,” Cellulose, IF 5.7 – Cited by 3 articles.

Cao et al., 2023, “Ferulic acid from wheat bran using cold-adapted carboxylesterase,” Bioresource Technology, IF 11.889 – Cited by 7 articles.

Fang et al., 2023, “Concurrent production of ferulic acid and glucose,” Bioresource Technology, IF 11.889 – Cited by 6 articles.

Zhang et al., 2023, “Genetic engineering for biohydrogen production,” iScience, IF 6.107 – Cited by 3 articles.

Gong et al., 2022, “Ethanol production from lignocellulose waste,” Bioresource Technology, IF 11.889 – Cited by 8 articles.

These publications demonstrate Dr. Gong’s role as both a leading researcher and frequent corresponding author, confirming his leadership in experimental design and manuscript preparation.

Conclusion

Dr. Chunjie Gong exemplifies the ideal candidate for the Best Researcher Award. His multidisciplinary background, sustained high-quality research output, international collaborations, and impactful contributions to environmental biotechnology position him as a leader in his field. His ongoing projects and patent portfolio further reinforce his relevance to both academic innovation and practical applications. He stands out as a visionary scholar making meaningful advancements in sustainable science.

Dilek Gungor | Biochemistry | Best Researcher Award

Mr. Dilek Gungor | Biochemistry | Best Researcher Award

Postdoctoral Researcher at Department of Basic Pharmaceutical Sciences, Faculty of Pharmacy, Hacettepe University, 06100 Ankara, Turkey

Dilek Güngör is a researcher in forensic biochemistry and nanomedicine with a strong academic background and multidisciplinary experience. Her work focuses on innovative drug delivery systems, particularly in combating antimicrobial resistance. Through research roles at both national institutions and internationally renowned universities, she has established a profile marked by scientific curiosity, methodical rigor, and impactful contributions to pharmaceutical and forensic sciences.

profile

orcid

Education

Dilek completed her Ph.D. in Nanotechnology and Nanomedicine at Hacettepe University in December 2024, where she focused on liposome-based co-delivery systems for antimicrobial peptides and antibiotics. Her doctoral studies included an international research stint at Rutgers University in the U.S., supported by TÜBİTAK 2214/A. She earned her M.Sc. in Biochemistry (Pharmacy) from Gazi University in February 2018 and her B.Sc. in Biochemistry with a specialization in Biotechnology from Ege University in June 2009. Her academic formation reflects a consistent commitment to molecular and pharmaceutical sciences, with thesis work investigating gene expressions in cancer and novel therapeutic delivery platforms.

Experience

Dilek has served as a Research Assistant at the Turkish National Police Academy across several departments since 2014, currently contributing to the Forensic Science Department. Between 2022 and 2023, she was a Visiting Scholar at Rutgers University’s Center for Dermal Research, deepening her expertise in transdermal drug delivery systems. Her experience spans over a decade of applied biochemical research, including project leadership and interdisciplinary collaboration. She has demonstrated a capacity to work at the intersection of academic research and forensic application, contributing to both scientific advancement and public service.

Research Interest

Her research interests include nanomedicine, forensic toxicology, and dermal drug delivery systems. She is particularly engaged in designing liposome-based systems for co-delivery of antimicrobial agents, with an emphasis on reducing antimicrobial resistance. Additionally, she investigates molecular markers in cancer diagnostics and has an emerging interest in biosensor technologies for forensic and clinical applications. Her research is characterized by translational intent, targeting real-world medical and forensic challenges through molecular innovation.

Awards

Dilek has been recognized with a TÜBİTAK 2214-A International Research Fellowship, allowing her to pursue advanced pharmaceutical research abroad. Earlier in her career, she contributed to a TÜBİTAK 2209-A project on biosensor development during her undergraduate studies. These fellowships underscore both her scientific promise and her capacity to lead cutting-edge research in nationally and internationally competitive contexts.

Publications

Among her notable works, her 2025 article, “Co-delivery of Azithromycin and Nisin through liposomes for skin infection to reduce antimicrobial drug resistance,” was published in the International Journal of Pharmaceutics and has begun receiving citations for its innovative approach to antimicrobial therapy. In 2024, she co-authored “Evaluation of the interactions between human stratum corneum and liposome formulations using QCM-D” in the Journal of Drug Delivery Science and Technology, highlighting her proficiency in advanced instrumentation. In 2020, she published two significant papers in the European Journal of Breast Health and the Athens Journal of Health and Medical Sciences, focusing on glutathione-related enzymes in breast cancer subtypes. Her earlier publication, “Sentetik uyuşturucular: Amfetamin örneği,” appeared in the Güvenlik Çalışmaları Dergisi in 2018 and reflects her forensic research contributions. Her most cited article is the 2025 IJPharm paper on liposomal drug delivery for antimicrobial resistance, which is increasingly referenced in pharmaceutical and clinical research circles.

Conclusion

Dr. Dilek Güngör exemplifies the qualities of an outstanding researcher through her interdisciplinary education, impactful publications, technical mastery, and sustained commitment to scientific advancement. Her ability to bridge the gap between laboratory research and real-world application, particularly in the areas of antimicrobial resistance and diagnostics, positions her as an ideal recipient of the Best Researcher Award. Her trajectory reflects both depth and breadth of expertise, making her a valuable asset to the scientific community at large